Abstract
Pregnancies of mothers with a history of Graves’ hyperthyroidism, previously treated, and those diagnosed at time of pregnancy are at higher risk of maternal and obstetrical complications as compared to a euthyroid population. Preconception patient education and contraception are imperative in women with thyroid disease, during the reproductive age. A medical team including endocrinologists, obstetricians, medical fetal-maternal physicians, anesthesiologists, neonatologist, and pediatric endocrinologists should be available from the time pregnancy is diagnosed. Antithyroid drug (ATD) therapy is the treatment of choice; thyroid surgery is indicated in selective cases. Selection of drug, timing of administration, and close follow-up with proper thyroid tests are essential for a good maternal and fetal outcome. Potential complications of ATD therapy should be considered and discussed with potential parents, as well as the interpretation of serum TRAb titers in detecting and treating thyroid fetal and neonatal disease. Breastfeeding recommendations and postpartum follow-up for a year following delivery is part of the care of a woman with a history of Graves’ hyperthyroidism.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Mutaba Q, Burrow N. Treatment of hyperthyroidism in pregnancy with Propylthiouracil and Methimazole. Obstet Gynecol. 1975;46:282–6.
Patil-Sisodia K, Mestman JH. Graves hyperthyroidism and pregnancy: a clinical update. Endocr Pract. 2010;16:118.
Cooper DS, Laurberg P. Hyperthyroidism in pregnancy. Lancet Diabetes Endocrinol. 2013;1:238–47.
Labadzhyan A, Brent G, Hershman JM, Leung AM. Thyrotoxicosis of pregnancy. J Clin Trans Endocrinol. 2014;1:140–4.
Krassas GE, Poppe K, Glineor D. Thyroid function and human reproductive health. Endocr Rev. 2010;31:702.
Mandel SL, Larsen PR, Seely EW, et al. Increased need for thyroxine during pregnancy in women with primary hypothyroidism. N Engl J Med. 1990;323:91.
Yassa L, Marqusee E, Fawcett R, et al. Thyroid hormone early adjustment in pregnancy: the THERAPY trial. J Clin Endocrinol Metab. 2010;95:3234–41.
Haddow JE, Palomaki GE, Allan WC, et al. Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N Engl J Med. 1999;341:549.
Peaceman A. Effect of treatment of maternal subclinical hypothyroidism and hypothyroxinemia on pregnancy outcomes. Am J Obstet Gynecol. 2016;214:S200.
Henrichs J, Bongers-Schokking JJ, Schenk JJ, et al. Maternal thyroid function during early pregnancy and cognitive functioning in early childhood: the generation R study. J Clin Endocrinol Metab. 2010;95:4227.
Abalovich M, Vazquez A, Alcaraz G, et al. Adequate levothyroxine doses for the treatment of hypothyroidism newly discovered during pregnancy. Thyroid. 2013;23:1479.
Laurberg P, Bournaud C, Karmisholt J, Orgiazzi J. Management Graves’ hyperthyroidism in pregnancy: focus on both maternal and foetal thyroid function, and caution against surgical thyroidectomy in pregnancy. Eur J Endocrinol. 2009;160:1–8.
Kautbally S, Alexopoulou O, Daumerie C, et al. Greater efficacy of total thyroidectomy versus radioiodine therapy in hyperthyroidism and thyroid stimulating immunoglobulin levels in patients with Graves’ disease previously treated with antithyroid drugs. Europ Thyrid J. 2012;1:122–8.
Bisschopp PH, van Trotsenburg AS. Images in clinical medicine. Neonatal thyrotoxicosis. N Engl J Med. 2014;370:1237.
Donnelly MA, Wood C, Casey B, et al. Early severe fetal Graves disease in a mother after thyroid ablation and thyroidectomy. Obstet Gynecol. 2015;125(5):1059–62.
Abeillon-du Payrat J, Chikh K, Bossard N, et al. Predictive values of maternal second-generation thyroid-binding inhibitory immunoglobulin assay for neonatal autoimmune hyperthyroidism. Eur J Endcor. 2014;171:451–60.
Hyer S, Pratt B, Newbold K, et al. Outcome of pregnancy after exposure to radioiodine in utero. Endocr Pract. 2011;17:1–10.
Sawka AM, Lakra DC, Lea J, et al. A systematic review examining the effects of therapeutic radioactive iodine on ovarian function and future pregnancy in female thyroid cancer survivors. Clin Endocrinol. 2008;69(3):479–92.
Glinoer D. Thyroid hyperfunction in pregnancy. Thyroid. 1998;8:859–64.
Hershman JM. Physiological and pathological aspects of the effect of human chorionic gonadotropin on the thyroid. Best Pract Res Clin Endocrinol Metabol. 2004;18:249–65.
Huang SA, Dorfman DM, Genest DR, Salvatore D, Larsen PR. Type 3 iodothyronine deiodinase is highly expressed in the human uteroplacental unit and in fetal epithelium. J Clin Endocrinol Metab. 2003;88:1384–8.
Hollowell JG, Haddow JE. The prevalence of iodine deficiency in women of reproductive age in the United States of America. Public Health Nutr. 2007;10:1532.
Yarrington DC, Pearce EN. Dietary iodine in pregnancy and postpartum. Clin Obstet Gynecol. 2001;54:459–70.
Li C, Shan Z, Mao J, et al. Assessment of thyroid function during first-trimester pregnancy: what is the rational upper limit of serum TSH during the first trimester in Chinese pregnant women? J Clin Endocrinol Metab. 2014;99(1):73.
Patel J, Landers K, Li H, et al. Delivery of maternal thyroid hormones to the fetus. Trends Endocrinol Metab. 2011;22:164.
Polak M, Van Vliet G. Therapeutic approach of fetal thyroid disorders. Hormone Res Pediatr. 2010;74:1–5.
Lee RH, Spencer CA, Mestman JH, et al. Free T4 immunoassays are flawed during pregnancy. Am J Obstet Gynecol. 2009;200:260.e1.
Bliddal S, Feldt-Rasmussen U, Boas M, et al. Gestational age-specific reference ranges from different laboratories misclassify pregnant women’s thyroid status: comparison of two longitudinal prospective cohort studies. Eur J Endocrinol. 2013;170(2):329.
Azizi F, Mehran L, Amouzegar A, et al. Establishment of the trimester-specific reference range for free thyroxine index. Thyroid. 2013;23(3):354.
Kahric-Janicic N, Soldin SJ, Soldin OP, West T, Gu J, Jonklaas J. Tandem mass spectrometry improves the accuracy of free thyroxine measurements during pregnancy. Thyroid. 2007;17:303.
Momotani N, Noh J, Oyanagi H, Ishikawa N, Ito K. Antithyroid drug therapy for Graves’ disease during pregnancy. Optimal regimen for fetal thyroid status. N Engl J Med. 1986;315:24–8.
Casey BM, Dashe JS, Wells CE, et al. Subclinical hyperthyroidism and pregnancy outcomes. Obstet Gynecol. 2006;107:337–41.
McLachlan SM, Rapoport B. Thyrotropin-blocking autoantibodies and thyroid stimulating Autoantibodies: potential mechanisms involved in the pendulum swinging form hypothyroidism to hyperthyroidism or vice versa. Thyroid. 2013;23:14–24.
Barbesibo G, Tomer Y. Clinica utility of TSH Receptor antibodies. J Clin Endoc Metabl. 2013;98:2247–013.
Brown RS, Bellasario RL, Botero D, et al. Incidence of transient congenital hypothyroidism due to maternal thyrotropin antibodies in over one million babies. J Clin Endocrinol Metab. 1996;81:1147.
Contempre B, Jauniaux E, Calvo R, et al. Detection of thyroid hormones inhuman embryonic cavities during the first trimester of pregnancy. J Clin Endocrinol Metab. 1993;77:1719.
Iskaros J, Pickard M, Evans I, et al. Thyroid hormone receptor gene expression in first trimester human fetus brain. J Clin Endocrinol Metab. 2000;85:2620.
Polak M, Le Gac I, Vuillard E, et al. Fetal and neonatal thyroid function in relation to maternal Graves’ disease. Best Prac Res Clin Endocrinol Metab. 2004;18:289–302.
Polak M, Luton D. Fetla thyroidology. Best practice and research. Clin Endocrinol Metabol. 2014;28:164–73.
Weetman AP. Immunity, thyroid function and pregnancy: molecular mechanisms. Nat Rev Endocrinol. 2010;6(6):311.
Abeillon-du PJ, Chikh K, Bossard N, et al. Predictive value of maternal second generation thyroid-binding inhibitory immunoglobulin assay for neonatal autoimmune hyperthyroidism. Eur J Endocrinol. 2014;171(4):451–60.
Goldman AM, Mestman JH. Transient non-autoimmune hyperthyroidism of early pregnancy. J Thyroid Res. 2011;2011:142413.
Goodwin TM, Hershman JM. Hyperthyroidism due to inappropriate production of human chorionic gonadotropin. Clin Obstet Gynecol. 1997;40:32–44.
Goodwin TM, Montoro M, Mestman JH. Transient hyperthyroidism and hyperemesis gravidarum: clinical aspects. Am J Obstet Gynecol. 1992;167(3):648L.
Fiaschi Nelson-Piercy C, Tata LJ. Hospital admission for hyperemesis gravidarum: a nationwide study of occurrence, reoccurrence and risk factors among 8.2 million pregnancies. Hum Reprod. 2016;31:1675–84.
Coulon AL, Savagner F, Briet C, et al. Prolonged and severe gestational thyrotoxicosis due to enhance hCG sensitivity to a mutant thyrotropin receptor. J Clin Endo Metab. 2016;101:10–1.
Tamaki H, Itoh E, Kaneda T, et al. Crucial role of serum human chorionic gonadotropin for the aggravation of thyrotoxicosis in early pregnancy in Graves’ disease. Thyroid. 1993;3:189.
Sheffield JS, Cunningham FG. Thyrotoxicosis and heart failure that complicate pregnancy. Am J Obstet Gynecol. 2004;190:211.
Easterling TR, Schmucker BC, Carlson KL, Millard SP, Benedetti TJ. Maternal hemodynamics in pregnancies complicated by hyperthyroidism. Obstet Gynecol. 1991;78:348–52.
Mannisto T, Mendola P, Grewal J, Xie Y, Chen Z, Laughon SK. Thyroid diseases and adverse pregnancy outcomes in a contemporary US cohort. J Clin Endocrinol Metab. 2013;98(7):2725.
Clark SL, Phelan JP, Montoro M, Mestman J. Transient ventricular dysfunction associated with cesarean section in a patient with hyperthyroidism. Am J Obstet Gynecol. 1985;151:384–6.
Millar LK, Wing DA, Leung AS, et al. Low birth weight and preeclampsia in pregnancies complicated by hyperthyroidism. Obstet Gynecol. 1994;84(6):946–9.
Aggarawal N, Suri V, Singla R, Chopra S, Sikka P, Shah VN,·Bhansali A. Pregnancy outcome in hyperthyroidism: a case control study Gynecol Obstet Investig 2014;77:94–99.
Luewan S, Chakkabut P, Tongsong T. Outcomes of pregnancy complicated with hyperthyroidism: a cohort study. Arch Gynecol Obstet. 2011;283(2):243.
Mitsuada N, Tamaki H, Amino N, et al. Risk factors for developmental disorders in infants born to women with Graves’ disease. Obstet Gynecol. 1992;80:359–64.
Kempers MJE, van Trotsenburg ASP, van Tijn DA. Disturbance of the fetal thyroid hormone state has long-term consequences for treatment of thyroidal and central congenital hypothyroidism. J Clin Endocriol Metab. 2005;90:4094.
Kempers MJ, van Trotsenburg AS, van Rijn RR, et al. Loss of integrity of thyroid morphology and function in children born to mothers with inadequately treated Graves’ disease. J Clin Endocrinol Metab. 2007;92:2984.
Papendieck P, Chiesa A, Prieto L, Grufieiro-Papendieck L. Thyroid disorders of neonates born to mothers with Graves’ disease. J Ped Endocr Metab. 2009;22:547.
Bahn RS, Burch HS, Cooper DS, et al. The role of propylthiouracil in the management of Graves’ disease in adults: report of a meeting jointly sponsored by the American Thyroid Association and the Food and Drug Administration. Thyroid. 2009;19:673–4.
Angell T, Lechner MG, Nguyen CT, Salvato VL, Nicoloff JT, LoPresti JS. Clinical features and hospital outcomes in thyroid storm: a retrospective cohort study. J Clin Endoc Metab. 2015;100:451–9.
Taylor PN, Vaidya B. Side effects of anti-thyroid drugs and their impact on the choice of treatment for thyrotoxicosis in pregnancy. Eur Thyroid J. 2012;1(3):176–85.
Andersen SL, Olsen J, Laurberg P. Antithyroid drug side effects in the population and in pregnancy. J Clin Endocrinol Metab. 2016;101:1606–14.
Mortimer Mortimer RH, Tyack SA, Galligan JP, et al. Graves’ disease in pregnancy: TSH receptor binding inhibiting immunoglobulins and maternal and neonatal thyroid function. Clin Endocrinol. 1990;32:14.
Rubin PC. Current concepts: beta-blockers in pregnancy. NEJM. 1981;305:1323–6.
Sherif IH, Oyan WT, Bosairi S, Carrascal SM. Treatment of hyperthyroidism in pregnancy. Acta Obstet Gynecol Scand. 1991;70:461–3.
Bowman ML, Bergmann M, Smith JF. Intrapartum labetalol for the treatment of maternal and fetal thyrotoxicosis. Thyroid. 1998;8:95–6.
Bruner JP, Landon MB, Gabbe SG. Diabetes mellitusand Graves’ disease in pregnancy complicated by maternalallergies to antithyroid medication. Obstet Gynecol. 1988;72:443–5.
Kuy S, Roman SA, Desai R, Sosa JA. Outcomes following thyroid and parathyroid surgery in pregnant women. Arch Surg. 2009;144(5):399.
Sheffield JS, Cunningham FG. Thyrotoxicosis and heart failure that complicate pregnancy. Am J Obstet Gynecol. 2004;190(1):211–7.
Burch HB, Wartofsky L. Life-threating thyrotoxicosis. Thyroid storm. Endocrinol Metab Clin North. 1993;22:263–77.
Akamizu T, Satoh T, Isozaki O, et al. Diagnostic criteria, clinical features, and incidence of thyroid storm based on nationwide surveys. Thyroid. 2012;22:661–79.
Fumarola A, Di Fiore A, Dainelli M, et al. Therapy of hyperthyroidism in pregnancy and breastfeeding. Obstet Gynecol Surv. 2011;66(6):378–85.
Milham S, Elledje W. Maternal methimazole and 70.- congenital defects in children. Teratology. 1972;5:125–6.
Cheron RG, Kaplan MM, Larsen PR, et al. Neonatal thyroid function after propylthiouracil therapy for maternal Graves’ disease. N Engl J Med. 1981;304:525.
Clementi M, Di Gianantonio E, Pelo E, Mammi I, Basile RT, Tenconi R. Methimazole embryopathy: Delineation of the phenotype. Am J Med Genet. 1999;83:43–66.
Foulds N, Walpole I, Elmslie F, Manour S. Carbimazole embryopathy: an emerging phenotype. Am J Med Genet. 2005;132A:130–5.
Andersen SL, Laurberg P. Antithyroid drugs and congenital heart defects: ventricular septal defect is part of the methimazole/Carbimazole embryopathy. Eur J Endocrinol. 2014;171:C1–3.
Besancon A, Beltrand J, Le Gac I, Luton D, Polak M. Management of neonates born to women with Graves’ disease: a cohort study. Europ J Endocrinol. 2014;170:855:862.
Andersen SL, Olsen J, Wu CS, Laurberg P. Birth defects after early pregnancy use of antithyroid drugs: a Danish nationwide study. J Clin Endocrinol Metabol. 2013;98:4373–81.
Yoshihara A, Noh J, Yamaguchi T, Ohye H, Sato S, Sekiya K, Kosuga Y, Suzuki M, Matsumoto M, Kunii Y, Watanabe N, Mukasa K, Ito K, Ito K. Treatment of Graves’ disease with antithyroid drugs in the first trimester of pregnancy and the prevalence of congenital malformation. J Clin Endocrinol Metab. 2012;97:2396–403.
Li H, Zheng J, Luo J, et al. Congenital anomalies in children exposed to antithyroid drugs in-utero: a meta-analysis of cohort studies. PLoS One. 2015;10(5):e01266140.
Ishikawa N. The relationship between neonatal developmental dysplasia of the hip and maternal hyperthyroidism. J Pediatr Orthop. 2008;20:432–4.
Finer LB, Zolna MR. Declines in unintended pregnancy in the United States, 2008-2011. N Engl J Med. 2016;374(9):843–52.
De Groot L, Abalovich M, Alexander EK, et al. Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2012;97(8):2543–65.
Stagnaro-Green A, Abalovich M, Alexdander E, et al. Guidelines of the American Thyroid Association for the Diagnosis and Management of thyroid disease during pregnancy and postpartum. Thyroid. 2011;21:1081.
Lazarus J, Brown RS, Daumerie C, Hubalewska-Dydejczyk A, Negro R, Vaidya B. 2014 European Thyroid Association Guidelines for the management of subclinical hypothyroidism in pregnancy and in children. Eur Thyroid J. 2014;3:76–94.
Laurberg P, Andersen SL. Antithyroid drug use in early pregnancy and birth defects: time windows of relative safety and high risk? Eur J Endocrinol. 2014;171:R13–20.
Korevaar TI, Muetzel R, Medici M, et al. Association of maternal thyroid function during early pregnancy with offspring IQ and brain morphology in childhood: a population-based prospective cohort study. Lancet Diabetes Endocrinol. 2016;4(1):35–43.
Towers CV, Thomas S, Steiger RM. The fetal heart monitor tracing in pregnancies complicate d by fetal thyrotoxicosis. Am J Perinat. 2009;26:373–7.
Luton D, LeGac I, Vuillard E, et al. Management of Graves’ disease during pregnancy: the key role of fetal thyroid gland monitoring. J Clin Endocrinol Metab. 2005;90:6093–8.
Ranzini AC, Ananth CV, Smulian JC, et al. Ultrasonography of the fetal thyroid: nomograms based on biparietal diameter and gestational age. J Ultrasound Med. 2011;20(6):613–7.
Nachum Z, Rakover Y, Weiner E, Shalev E. Graves’ disease in pregnancy: prospective evaluation of a selective invasive treatment protocol. Am J Obstet Gynecol. 2003;189:159–65.
Bliddal S, Rasmussen AK, Sundberg K, et al. Antithyroid drug-induced fetal goitrous hypothyroidism. Nat Rev Endocrinol. 2011;7(7):396–406.
Levy-Shraga Y, Tamir-Hostovsky L, Boyko V, et al. Follow-up of newborns of mothers with Graves’ disease. Thyroid. 2014;24(6):1032–9.
Momotani N, Noh J, Ishikawa N, et al. Relationship between silent thyroiditis and recurrent Graves’ disease in the postpartum period. J Clin Endocrinol Metab. 1994;79:285.
Amino N, Tada H, Hidaka Y. Postpartum autoimmune thyroid syndrome: a model of aggravation f autoimmune disease. Thyroid. 1999;9:705–13.
Tada H, Hidaka Y, Tsuruta E, et al. Prevalence of postpartum onset of disease within patients with Graves’ disease of child-bearing age. Endocr J. 1994;41:325–7.
Benhaim Rochester D, Davies TF. Increased risk of Graves’ disease after pregnancy. Thyroid. 2005;15:1287–90.
Stagnaro Green A, Schawartz A, Gismondi R, et al. High rate of persistent hypothyroidism in a large-scale prospective study of postpartum thyroiditis in southern Italy. J Clin Endocr Metab. 2011;96:652–7.
Ide A, Amino N, Kang S, et al. Differentiation of postpartum Graves’ thyrotoxicosis from postpartum destructive thyrotoxicosis using antithyrotropin receptor antibodies and thyroid blood flow. Thyroid. 2014;24:1027.
Yoshihara A, Noh JY, Watanabe N, et al. Lower incidence of postpartum thyrotoxicosis in women with Graves disease treated by radioiodine therapy than by subtotal thyroidectomy or with antithyroid drugs. Clin Nucl Med. 2014;39(4):326.
Momotani N, Yamashita R, Makino F, Noh JY, Ishikawa N, Ito K. Thyroid function in wholly breast-feeding infants whose mothers take high doses of propylthiouracil. Clin Endocrinol. 2000;53:177–81.
Azizi F, Khoshniat M, Bahrainian M, Hedayati M. Thyroid function and intellectual development of infants nursed by mothers taking methimazole. J Clin Endocrinol Metab. 2000;85:3233–8.
Karras S, Krassas GE. Breastfeeding and antithyroid drugs: a view from within. Eur Thyroid J. 2012;1(1):30–3.
Refetoff S, DeWind LT, DeGroot LJ. Familial syndrome combining deaf mutism, stippled epiphyses, goiter and abnormally high PBI: possible target organ refractoriness to thyroid hormone. J Clin Endocrinol Metab. 1967;27:279.
Weiss RE, Dumitrescu A, Refetoff S. Approach to the patient with resistance to thyroid hormone and pregnancy. J Clin Endoc Metab. 2010;95:3094–100.
Anselmo J, Cao D, Karrison T, et al. Fetal loss associated with excess thyroid hormone exposure. JAMA. 2004;292:691.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Mestman, J.H. (2019). Hyperthyroidism and Pregnancy. In: Luster, M., Duntas, L., Wartofsky, L. (eds) The Thyroid and Its Diseases. Springer, Cham. https://doi.org/10.1007/978-3-319-72102-6_48
Download citation
DOI: https://doi.org/10.1007/978-3-319-72102-6_48
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-72100-2
Online ISBN: 978-3-319-72102-6
eBook Packages: MedicineMedicine (R0)